DOJ, EUSA Pharma settle false claims action
Compliance Monitor, March 28, 2012
EUSA Pharma, a radiopharmceutical company based in Langhorne, Pa., has agreed to pay $180,000 to settle false claims allegations stemming from its suspected practice of encouraging providers to submit inflated claims to Medicare, according to a March 23 Department of Justice press release.
The Society of Nuclear Medicine informed the company that only one claim may be submitted for scans using ProstaScint, a EUSA Pharma product, according to court documents. However, EUSA Pharma still encouraged providers to submit multiple claims for images.
Read more on the U.S. Department of Justice website.
Related Products
Most Popular
- Articles
-
- Don't forget the three checks in medication administration
- Note similarities and differences between HCPCS, CPT® codes
- Nursing responsibilities for managing pain
- Practice the six rights of medication administration
- The consequences of an incomplete medical record
- Prevent dehydration with nursing interventions
- Q&A: Primary, principal, and secondary diagnoses
- Steps for maintaining patient privacy
- Know the medical gas cylinder storage requirements
- Neurological checks for head injuries
- E-mailed
-
- Understand the spine to code back procedures correctly
- Q/A: Correct use of modifier -PT
- Q&A: Use yes/no queries to resolve surgical complication questions
- Get to the heart of cardiac catheterization coding
- Documentation challenges for skin and dermatology coding
- Clinically Speaking: Check CDI efforts related to functional quadriplegia
- Searched